{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:30:47Z","timestamp":1764401447023},"reference-count":37,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.vaccine.2003.12.008","type":"journal-article","created":{"date-parts":[[2004,1,22]],"date-time":"2004-01-22T10:20:17Z","timestamp":1074766817000},"page":"2599-2608","source":"Crossref","is-referenced-by-count":21,"title":["Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone"],"prefix":"10.1016","volume":"22","author":[{"given":"Eiji","family":"Mutoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyokazu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Takamizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsutaro","family":"Sata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asato","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.12.008_BIB1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.1996.tb124960.x","article-title":"An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995","volume":"165","author":"Hanna","year":"1996","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB2","first-page":"49","article-title":"Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australia","volume":"267","author":"Mackenzie","year":"2002","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB3","first-page":"11","article-title":"Japanese encephalitis virus: ecology and epidemiology","volume":"267","author":"Endy","year":"2002","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB4","first-page":"139","article-title":"Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control","volume":"267","author":"Igarashi","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0264-410X(00)00037-2","article-title":"New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO\/CVI Meeting, Bangkok, Thailand, 13\u201315 October 1998","volume":"18","author":"Tsai","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB6","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0264-410X(97)00195-3","article-title":"Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization Meeting","volume":"15","author":"Chambers","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB7","first-page":"340","article-title":"Development of an inactivated Japanese encephalitis vaccine by utilizing a continuous cell line","volume":"26","author":"Ishikawa","year":"1998","journal-title":"Clin. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB8","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/S0264-410X(01)00208-0","article-title":"A purified inactivated Japanese encephalitis virus vaccine made in Vero cells","volume":"19","author":"Srivastava","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/biol.2002.0345","article-title":"Development of Vero cell-derived inactivated Japanese encephalitis vaccine","volume":"30","author":"Sugawara","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000050045","article-title":"Development of new vaccines against dengue fever and Japanese encephalitis","volume":"44","author":"Kinney","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB11","first-page":"105","article-title":"Japanese encephalitis vaccines: current vaccines and future prospects","volume":"267","author":"Monash","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0168-1702(96)01343-3","article-title":"A highly attenuated strain of Japanese encephalitis virus induces a protective immune response in mice","volume":"44","author":"Lin","year":"1996","journal-title":"Virus Res."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB14","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/JVI.64.6.2788-2795.1990","article-title":"Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express prM and E glycoproteins of Japanese encephalitis virus","volume":"64","author":"Yasuda","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB15","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB17","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB18","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/JVI.74.9.4244-4252.2000","article-title":"A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice","volume":"74","author":"Chang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB19","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JVI.72.6.4925-4930.1998","article-title":"Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes","volume":"72","author":"Konishi","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0065-3527(00)55005-2","article-title":"Structures and mechanisms in flavivirus fusion","volume":"55","author":"Heinz","year":"2000","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB21","unstructured":"Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed., vol. 1. Philadelphia, Lippincott: Williams & Wilkins; 2001. p. 991\u20131041."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB22","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1128\/JVI.73.12.10137-10145.1999","article-title":"Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines","volume":"73","author":"Chen","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB23","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","article-title":"Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies","volume":"141","author":"Kimura-Kuroda","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB24","first-page":"91","article-title":"Immune responses to Japanese encephalitis virus","volume":"267","author":"Kurane","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB25","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","article-title":"Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein","volume":"70","author":"Mason","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB26","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/JVI.67.3.1672-1675.1993","article-title":"Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein","volume":"67","author":"Konishi","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/viro.1993.1064","article-title":"High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by NS3 gene product","volume":"192","author":"Sato","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2003.12.008_BIB28","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1099\/0022-1317-71-9-2107","article-title":"The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherihia coli","volume":"71","author":"Mason","year":"1990","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.12.008_BIB29","first-page":"303","article-title":"Studies in the development of Japanese encephalitis vaccine: expression of virus envelope glycoprotein V3 (E) gene in yeast","volume":"65","author":"Fujita","year":"1987","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB30","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1099\/0022-1317-72-6-1323","article-title":"Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions","volume":"72","author":"Guirakhoo","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB32","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/JVI.70.7.4549-4557.1996","article-title":"Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions","volume":"70","author":"Schalich","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB33","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1128\/JVI.77.16.8745-8755.2003","article-title":"Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus E protein for a second-generation subunit vaccine","volume":"77","author":"Kojima","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4269\/ajtmh.1958.7.561","article-title":"Techniques for hemagglutination and hemagglutination-inhibition with arthropod borne viruses","volume":"7","author":"Clarke","year":"1958","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB35","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1099\/0022-1317-72-10-2509","article-title":"Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study","volume":"67","author":"Hoshikawa","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2003.12.008_BIB36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0042-6822(89)90580-1","article-title":"Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses","volume":"173","author":"Matsuura","year":"1989","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.vaccine.2003.12.008_BIB37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/0264-410X(94)90329-8","article-title":"Towards a new generation of flavivirus vaccines","volume":"12","author":"Venugopal","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T19:30:47Z","timestamp":1682623847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":37,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0264410X03008788"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.12.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}